tiprankstipranks
Aurinia Pharmaceuticals (AUPH)
NASDAQ:AUPH

Aurinia Pharmaceuticals (AUPH) Financial Statements

1,873 Followers

Aurinia Pharmaceuticals Financial Overview

Aurinia Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-0.545; its P/E ratio is -9.17; Aurinia Pharmaceuticals is scheduled to report earnings on May 15, 2024, and the estimated EPS forecast is $-0.14. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 45.09M$ 54.52M$ 41.49M$ 34.41M$ 28.43M
Gross Profit$ 39.70M$ 47.75M$ 39.93M$ 33.99M$ 27.07M
EBIT$ -25.75M$ -11.75M$ -11.43M$ -25.77M$ -28.10M
EBITDA$ -24.10M$ -11.75M$ -13.70M$ -27.66M-
Net Income Common Stockholders$ -26.88M$ -13.45M$ -11.49M$ -26.21M$ -26.05M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 350.49M$ 337.90M$ 350.71M$ 361.53M$ 389.39M
Total Assets$ 548.06M$ 555.01M$ 548.90M$ 451.76M$ 470.86M
Total Debt$ 97.61M$ 93.21M$ 101.21M$ 7.93M$ 8.09M
Net Debt$ -252.88M$ -244.69M$ -249.51M$ -353.60M$ -381.30M
Total Liabilities$ 170.11M$ 163.14M$ 156.61M$ 61.35M$ 65.42M
Stockholders Equity$ 377.95M$ 391.88M$ 392.29M$ 390.41M$ 405.44M
Cash Flow-
Free Cash Flow$ 14.25M-$ -3.05M$ -32.18M$ 10.32M
Operating Cash Flow$ 14.31M-$ -2.83M$ -31.67M$ 10.45M
Investing Cash Flow$ -6.26M-$ -5.61M$ 24.86M$ -3.02M
Financing Cash Flow$ -5.58M-$ 1.14M$ 1.64M$ 688.00K
Currency in USD

Aurinia Pharmaceuticals Earnings and Revenue History

Aurinia Pharmaceuticals Debt to Assets

Aurinia Pharmaceuticals Cash Flow

Aurinia Pharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis